PLAIO

Reykjavik, Iceland Founded: 2021 • Age: 5 yrs
AI-based planning solutions are provided for pharmaceutical industries.
Annual revenue - Latest available
Total funding $7.1M 3 rounds
Employees - Tracked headcount
Investors 4 Known backers
Products 4 Services tracked
Competitors 9 Brand Intelligence

About PLAIO

PLAIO is a company based in Reykjavik (Iceland) founded in 2021. PLAIO has raised $7.09 million across 3 funding rounds from investors including Kvika, Rannis and Frumtak Ventures. PLAIO offers products and services including Demand Planning, Manufacturing Planning, Purchase Planning, and PLAIO Coplanner. PLAIO operates in a competitive market with competitors including Apprentice, Aizon, Enzyme Technology, LunarTree and BatchLine, among others.

  • Headquarter Reykjavik, Iceland
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $7.09 M (USD)

    in 3 rounds

  • Latest Funding Round
    $4.71 M (USD), Series A

    Aug 14, 2024

  • Investors
    Kvika

    & 3 more

  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of PLAIO

PLAIO offers a comprehensive portfolio of products and services, including Demand Planning, Manufacturing Planning, Purchase Planning, and PLAIO Coplanner.

Product name locked
Category locked
Primary

Centralizes market demand for accurate forecasting and analysis.

Product name locked
Category locked
Locked

Optimizes production schedules and capacity estimation processes.

Product name locked
Category locked
Locked

Manages inventory and procurement for improved service levels.

Product name locked
Category locked
Locked

Offers AI-based assistance for supply chain decisions.

People of PLAIO

Headcount 10-50
Employee Profiles 6
Employee Profiles
People
Manuela Magnúsdóttir
VP Of Products
People
Christian Hartvig
Head of Business Development Europe
People
Johann Gudbjargarson
Founder & CEO

Unlock access to complete

Funding Insights of PLAIO

PLAIO has successfully raised a total of $7.09M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $4.71 million completed in August 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in PLAIO

PLAIO has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Kvika, Rannis and Frumtak Ventures.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Venture capital investments are made in innovative Icelandic startups.
Locked Locked Locked
Commercial banking services are provided in Reykjavik, Iceland.
Locked Locked Locked
Production of vitamins, minerals, and food supplements in the Czech Republic.
Locked Locked Locked
Premium access

Investor details for PLAIO

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by PLAIO

Investments
Premium access

Investment portfolio details for PLAIO

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - PLAIO

Premium access

Detailed financials for PLAIO

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Plaio Comparisons

PLAIO Primary company
Description
AI-based planning solutions are provided for pharmaceutical ...
Location
Reykjavik, Iceland
Founded Year
2021
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for PLAIO

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of PLAIO

PLAIO operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Apprentice, Aizon, Enzyme Technology, LunarTree and BatchLine, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
AI-based tools for pharmaceutical manufacturing management are offered.
Locked Locked Locked
AI-based software for manufacturing operations is provided.
Locked Locked Locked
AI-based enzymatic DNA synthesis technology is provided for researchers.
Locked Locked Locked
AI platform aggregates biopharma data for accelerated life sciences decisions.
Locked Locked Locked
Offers SaaS-based electronic batch processing software for pharmaceutical manufacturers.
Premium access

Detailed competitors of PLAIO

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Plaio

Premium access

Complete news archive for PLAIO

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about PLAIO

PLAIO was founded in 2021.

PLAIO is headquartered in Reykjavik, Iceland.

PLAIO is a funded company, having raised a total of $7.09M across 3 funding rounds to date.

PLAIO was founded in 2021 and is headquartered in Reykjavik, Iceland. AI-driven planning solutions are offered by the company to the pharmaceutical sector, focusing on operational efficiency in manufacturing facilities. Three core modules are included: demand planning, manufacturing planning, and purchase planning. These tools are designed to facilitate on-time production and resource management across pharmaceutical operations.

PLAIO's top competitors include Apprentice, Aizon and Enzyme Technology.

PLAIO offers Demand Planning, Manufacturing Planning, Purchase Planning, and PLAIO Coplanner.

PLAIO has 4 investors. Key investors include Kvika, Rannis, Frumtak Ventures, and VITAR.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available